Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 32NETWORK 12OTHER_GOV 3NIH 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Sarcoma 2Gynecologic 1Gastrointestinal 1

Conditions

Sarcoma 2Neoplasm Metastasis 1Colorectal Neoplasms 1Cervical Cancer Susceptible Population Classification 1

Interventions

Cisplatin 49Capecitabine 42Radiotherapy 33Oxaliplatin 33Gemcitabine 33apatinib 32Cyclophosphamide 32Drug Therapy 31Paclitaxel 30Carboplatin 29tislelizumab 27Irinotecan 27Fluorouracil 26Docetaxel 26Bevacizumab 23Surgical Procedures, Operative 20Nivolumab 19pembrolizumab 18fludarabine 18Metformin 16Exercise 16Radiation 15camrelizumab 14S 1 (combination) 14Control Groups 14Blood Specimen Collection 14Pemetrexed 13Standard of Care 12anlotinib 11Neoadjuvant Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER_GOV × Base Sequence × Clear all
NCT03784014 2026-04-29

MULTISARC

Institut National de la Santé Et de la Recherche Médicale, France

Phase 3 Completed
603 enrolled
Sarcoma

Neoplasm Metastasis, Sarcoma

NCT03546127 2025-09-11

MULTIPLI-0

Institut National de la Santé Et de la Recherche Médicale, France

Completed
24 enrolled
GastrointestinalSarcoma

Sarcoma, Colorectal Neoplasms

NCT06405945 2024-05-09

Cervical Cancer Susceptible Population Classification

Anhui Provincial Hospital

Recruiting
10,000 enrolled
Gynecologic

Cervical Cancer Susceptible Population Classification

Data powered by HemOnc (CC BY 4.0) Colophon âš¡